Cargando…
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
At present, clinical interventions for chronic kidney disease are very limited, and most patients rely on dialysis to sustain their lives for a long time. However, studies on the gut–kidney axis have shown that the gut microbiota is a potentially effective target for correcting or controlling chroni...
Autores principales: | Pan, Libin, Yu, Hang, Fu, Jie, Hu, Jiachun, Xu, Hui, Zhang, Zhengwei, Bu, Mengmeng, Yang, Xinyu, Zhang, Haojian, Lu, Jinyue, Jiang, Jiandong, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149897/ https://www.ncbi.nlm.nih.gov/pubmed/37139409 http://dx.doi.org/10.1016/j.apsb.2022.12.010 |
Ejemplares similares
-
Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesterase
por: Yu, Hang, et al.
Publicado: (2023) -
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
por: Wang, Jingyue, et al.
Publicado: (2023) -
Gut Microbiota Dynamics and Uremic Toxins
por: Mishima, Eikan, et al.
Publicado: (2022) -
The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021) -
Gut Microbiota as a Source of Uremic Toxins
por: Popkov, Vasily A., et al.
Publicado: (2022)